Navidea Biopharmaceuticals IncのSMA 50
Navidea Biopharmaceuticals IncのSMA 50は何ですか。
Navidea Biopharmaceuticals IncのSMA 50は$0 +100.00%です。
SMA 50の定義は何ですか。
SMA 50は、過去50日間の終値の非加重平均として計算された過去50日間の平均株価である。
Simple moving average of 50 days for a stock is an unweighted moving average over the past 50 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
NYSEMKTのセクタHealth CareにおけるSMA 50の企業と比べるNavidea Biopharmaceuticals Inc
Navidea Biopharmaceuticals Incは何をしますか。
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Navidea Biopharmaceuticals Incと類似のsma 50
- Navidea Biopharmaceuticals IncのSMA 50は$0 +100.00%です。
- EVmo IncのSMA 50は$0 +99.75%です。
- Blue Capital Reinsurance LtdのSMA 50は$0 -Inf%です。
- Kaleido Biosciences IncのSMA 50は$0 +59.40%です。
- Yangtze River Port and Logistics LtdのSMA 50は$0 +28.25%です。
- iFresh IncのSMA 50は$0 +0.00%です。
- Aridis Pharmaceuticals IncのSMA 50は$0 +83.25%です。